« Back
Home /
Apimostinel

Apimostinel

Item no.	HY-102053-10mM
Manufacturer	MedChem Express
CASRN	1421866-48-9
Amount	10mM*1 mL
Quantity options	100 mg 10mM*1 mL 10 mg 25 mg 50 mg 5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	99.04
Citations	[1]Naurex's First Orally Active Molecule, NRX-1074, Demonstrates Statistically Significant Improvement in Depression Scores within 24 Hours in Phase 2 Study for Major Depressive Disorder. January 28, 2015.
Smiles	C[C@@H](O)[C@@H](C(N)=O)NC([C@@]1(CC2=CC=CC=C2)N(C([C@H]3N(C([C@H]([C@H](O)C)N)=O)CCC3)=O)CCC1)=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	NRX-1074; AGN-241660
Available
Product Description	Apimostinel (NRX-1074; AGN-241660) is an orally active NMDA receptor partial agonist[1].
StorageTemperature	4°C (Powder, stored under nitrogen)
Shipping	Room Temperature
Manufacturers Applications	Neuroscience-Neurodegeneration
MolecularWeight	503.59
Clinical Information	Phase 2
Manufacturers Research Area	Neurological Disease
Solubility	DMSO : 155 mg/mL (ultrasonic)\|H2O : ≥ 6.67 mg/mL
Target	iGluR
Manufacturers Target	iGluR
Isoform	NMDA Receptor
Manufacturers Pathway	Membrane Transporter/Ion Channel; Neuronal Signaling
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-102053-10mM-safety-datasheet.pdf